PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Prednisolone - Inflammatory bowel disease

PAD Profile : Prednisolone - Inflammatory bowel disease

Keywords :
IBD, chronic bowel disorders, UC, Ulcerative colitis, Crohn's disease
Brand Names Include :
Predfoam

Traffic Light Status

Status 1 of 5.

Status :
Non Formulary
Important
Formulations :
  • Foam enema
Important Information :
Budesonide rectal foam is preferred. Steroid safety considerations
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
Comments :
No comments returned.
Documents :

Status 2 of 5.

Status :
Green
Important
Formulations :
  • Tablets
Important Information :
Tablets can be dispersed for immediate administration.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 3 of 5.

Status :
Green
Important
Formulations :
  • Soluble tablets
Important Information :
Paediatrics only at SASH. Paediatrics and oncology at ASPH
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 4 of 5.

Status :
Green
Important
Formulations :
  • Oral solution
Important Information :
Paediatric doses and NG/NJ tube only
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 5 of 5.

Status :
Non Formulary
Important
Formulations :
  • Gastro-resistant tablets
Important Information :
Enteric coated tablets - non-formulary
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
13 March 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN does not recommend Prednisolone foam enemas as a treatment option for patients with active Ulcerative Colitis Prednisolone foam enemas will be considered BLACK, for new patients, on the traffic light system People who are currently receiving prednisolone foam enema should have the option to continue therapy from their usual prescriber until they and their clinicians consider it appropriate to stop. Primary care prescribers should consider switching patients to budesonide rectal foam and for all new patients.

Associated BNF Codes

01. Gastro-Intestinal System
01.05.02. Corticosteroids
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More